Literature DB >> 11857458

Capillary plexus development in the day five to day six chick chorioallantoic membrane is inhibited by cytochalasin D and suramin.

Goar Melkonian1, Nicole Munoz, Jeanne Chung, Cathy Tong, Rebecca Marr, P Talbot.   

Abstract

The chick chorioallantoic membrane (CAM) is a valuable model for evaluating angiogenesis and vasculogenesis. Our purpose was to characterize the formation of the CAM vasculature, in particular the capillary plexus, between days five and six after fertilization and to examine the mode of action of cytochalasin D and suramin on vascular development during this interval. The CAM increased 20-fold in size between days five and six, during which time the capillary plexus forms by both migration of mesodermal blood vessels toward the ectoderm and by the formation of new vessels from angioblasts near the ectoderm. Between days five and six, the CAM becomes thinner, and the density of the mesodermal cells decreases. To determine the mode of action of anti-angiogenic drugs on the day five to day six CAM, various concentrations of cytochalasin D or suramin were added directly to day five CAMs, and their effects were evaluated on day six. Both drugs significantly inhibited CAM growth, altered branching patterns of the major vessels, decreased area of the major vessels, and inhibited the formation of the capillary plexus by inhibiting both vasculogenesis and the migration of mesodermal blood vessels to the ectoderm. Cytochalasin D also inhibited compartmentalization of the plexus. Cytochalasin D and suramin were inhibitory at similar doses. This study provides new information on early CAM development, establishes the mode of action and dose dependency of cytochalasin D and suramin on day five to day six CAMs, and demonstrates that the day five to day six CAM provides a useful assay to examine the effect of anti-angiogenic drugs on blood vessel development, including capillary plexus formation. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11857458     DOI: 10.1002/jez.10014

Source DB:  PubMed          Journal:  J Exp Zool        ISSN: 0022-104X


  10 in total

Review 1.  The chick chorioallantoic membrane: a model of molecular, structural, and functional adaptation to transepithelial ion transport and barrier function during embryonic development.

Authors:  Maria Gabriella Gabrielli; Daniela Accili
Journal:  J Biomed Biotechnol       Date:  2010-03-21

2.  Identification of an Endogenously Generated Cryptic Collagen Epitope (XL313) That May Selectively Regulate Angiogenesis by an Integrin Yes-associated Protein (YAP) Mechano-transduction Pathway.

Authors:  Jacquelyn J Ames; Liangru Contois; Jennifer M Caron; Eric Tweedie; Xuehui Yang; Robert Friesel; Calvin Vary; Peter C Brooks
Journal:  J Biol Chem       Date:  2015-12-14       Impact factor: 5.157

3.  Chapter 2. Chick embryo chorioallantoic membrane models to quantify angiogenesis induced by inflammatory and tumor cells or purified effector molecules.

Authors:  Elena I Deryugina; James P Quigley
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

Review 4.  Chick embryo chorioallantoic membrane model systems to study and visualize human tumor cell metastasis.

Authors:  Elena I Deryugina; James P Quigley
Journal:  Histochem Cell Biol       Date:  2008-11-13       Impact factor: 4.304

Review 5.  The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis.

Authors:  Domenico Ribatti
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-08

6.  Methanolic extract of Euchelus asper exhibits in-ovo anti-angiogenic and in vitro anti-proliferative activities.

Authors:  Sweta Agrawal; Sachin Chaugule; Shashank More; Gargi Rane; Madhavi Indap
Journal:  Biol Res       Date:  2017-12-12       Impact factor: 5.612

7.  An angiogenesis platform using a cubic artificial eggshell with patterned blood vessels on chicken chorioallantoic membrane.

Authors:  Wenjing Huang; Makoto Itayama; Fumihito Arai; Katsuko S Furukawa; Takashi Ushida; Tomohiro Kawahara
Journal:  PLoS One       Date:  2017-04-17       Impact factor: 3.240

8.  CAM-Delam: an in vivo approach to visualize and quantify the delamination and invasion capacity of human cancer cells.

Authors:  Tamilarasan K Palaniappan; Lina Šlekienė; Anna-Karin Jonasson; Jonathan Gilthorpe; Lena Gunhaga
Journal:  Sci Rep       Date:  2020-06-26       Impact factor: 4.379

Review 9.  Microvascular Experimentation in the Chick Chorioallantoic Membrane as a Model for Screening Angiogenic Agents including from Gene-Modified Cells.

Authors:  Donna C Kennedy; Barbara Coen; Antony M Wheatley; Karl J A McCullagh
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 5.923

10.  Comparison of effects of anti-angiogenic agents in the zebrafish efficacy-toxicity model for translational anti-angiogenic drug discovery.

Authors:  Geetanjali Chimote; Jayasree Sreenivasan; Nilambari Pawar; Jyothi Subramanian; Hariharan Sivaramakrishnan; Somesh Sharma
Journal:  Drug Des Devel Ther       Date:  2014-08-19       Impact factor: 4.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.